I-MAB

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell I-MAB and other ETFs, options, and stocks.

About IMAB

I-Mab operates as a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel or differentiated biologics to treat diseases with unmet medical needs, particularly cancers and autoimmune disorders. The company was founded by Jingwu Zang on June 30, 2016 and is headquartered in Pudong, China. 

CEO
Rajkumar Kannan
CEORajkumar Kannan
Employees
220
Employees220
Headquarters
Pudong, Shanghai
HeadquartersPudong, Shanghai
Founded
2016
Founded2016
Employees
220
Employees220

IMAB Key Statistics

Market cap
139.03M
Market cap139.03M
Price-Earnings ratio
-0.68
Price-Earnings ratio-0.68
Dividend yield
—
Dividend yield—
Average volume
175.58K
Average volume175.58K
High today
$1.83
High today$1.83
Low today
$1.77
Low today$1.77
Open price
$1.81
Open price$1.81
Volume
44.96K
Volume44.96K
52 Week high
$3.45
52 Week high$3.45
52 Week low
$1.16
52 Week low$1.16
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.